Statement from the REMAP-CAP trial
Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms…
Statement from the REMAP-CAP trial: International Trials of Blood Thinners Pause Enrolment of Critically Ill COVID-19 Patients Three clinical trial platforms…
Coronavirus spread during dental procedures could be reduced with slower drill rotation: Researchers from Imperial College London and King’s College London…
Sir Patrick Vallance delivers Hammersmith and White City Distinguished Lecture: Government Chief Scientific Adviser, Sir Patrick Vallance, spoke on science…
Beta-blockers are used to prevent internal bleeding in patients with liver cirrhosis and portal hypertension. Researchers from MedUni Vienna have…
A new study, led by experts from the University of Nottingham, has shown that people with rare autoimmune rheumatic diseases…
A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing. The chip, developed at…
Liver cirrhosis: new study on the impact of systemic inflammation on disease progression: Patients with liver cirrhosis display a wide…
We are excited to share a new short film with you to hear how we at the Foundation plan to…
Introducing the HIV Commission to mark World AIDS Day: Kat Smithson is director of policy at the National AIDS Trust…
HIV treatments - where we are today and what's next: Despite the ambitious 2020 goals set by UNAIDS 90-90-90 not being reached, innovative…
This website uses cookies.